NASDAQ:NYMX - Nymox Pharmaceutical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.69 -0.05 (-2.87 %) (As of 10/21/2018 10:05 AM ET)Previous Close$1.69Today's Range$1.6662 - $1.8052-Week Range$1.61 - $4.60Volume60,507 shsAverage Volume232,012 shsMarket Capitalization$96.68 millionP/E RatioN/ADividend YieldN/ABeta0.49 Company ProfileDiscussionChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207) that has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia; and is in Phase II clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company markets its products in Canada, the United States, Europe, and internationally. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas. Receive NYMX News and Ratings via Email Sign-up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical SymbolNASDAQ:NYMX CUSIPN/A Webwww.nymox.com Phone800-936-9669 Debt Debt-to-Equity RatioN/A Current Ratio3.19 Quick Ratio3.17 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$220,000.00 Price / Sales439.48 Cash FlowN/A Price / CashN/A Book Value($0.02) per share Price / Book-84.50 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-13,420,000.00 Net Margins-3,455.58% Return on Equity-4,095.76% Return on Assets-585.27% Miscellaneous EmployeesN/A Outstanding Shares57,210,000Market Cap$96.68 million Nymox Pharmaceutical (NASDAQ:NYMX) Frequently Asked Questions What is Nymox Pharmaceutical's stock symbol? Nymox Pharmaceutical trades on the NASDAQ under the ticker symbol "NYMX." How were Nymox Pharmaceutical's earnings last quarter? Nymox Pharmaceutical Corp (NASDAQ:NYMX) posted its quarterly earnings data on Monday, August, 13th. The biopharmaceutical company reported ($0.04) EPS for the quarter. The biopharmaceutical company had revenue of $0.09 million for the quarter. Nymox Pharmaceutical had a negative net margin of 3,455.58% and a negative return on equity of 4,095.76%. View Nymox Pharmaceutical's Earnings History. When is Nymox Pharmaceutical's next earnings date? Nymox Pharmaceutical is scheduled to release their next quarterly earnings announcement on Monday, November 5th 2018. View Earnings Estimates for Nymox Pharmaceutical. Who are some of Nymox Pharmaceutical's key competitors? Some companies that are related to Nymox Pharmaceutical include Quotient (QTNT), Trinity Biotech (TRIB), Celldex Therapeutics (CLDX), ImmuCell (ICCC), Vermillion (VRML), Riot Blockchain (RIOT), Akers Biosciences (AKER), Achieve Life Sciences (ACHV), Arca Biopharma (ABIO), GeneNews (GNWSF), Fluoropharma Medical (FPMI), BG Medicine (BGMD), Response Genetics (RGDXQ) and Palatin Technologies (PTN). Who are Nymox Pharmaceutical's key executives? Nymox Pharmaceutical's management team includes the folowing people: Dr. Paul Averback, Founder, Chairman, CEO & Pres (Age 67)Mr. Erik Danielsen, Chief Financial Officer (Age 55)Mr. Randall J. Lanham, Gen. Counsel, Sec. & Director (Age 54)Dr. Judith Fitzpatrick Ph.D., Exec. (Age 69)Dr. Suresh Kalbag M.D., Director of CMC Operations How do I buy shares of Nymox Pharmaceutical? Shares of NYMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Nymox Pharmaceutical's stock price today? One share of NYMX stock can currently be purchased for approximately $1.69. How big of a company is Nymox Pharmaceutical? Nymox Pharmaceutical has a market capitalization of $96.68 million and generates $220,000.00 in revenue each year. What is Nymox Pharmaceutical's official website? The official website for Nymox Pharmaceutical is http://www.nymox.com. How can I contact Nymox Pharmaceutical? Nymox Pharmaceutical's mailing address is 9900 CAVENDISH BLVD. SUITE 306, ST. LAURENT A8, H4M 2V2. The biopharmaceutical company can be reached via phone at 800-936-9669 or via email at [email protected] MarketBeat Community Rating for Nymox Pharmaceutical (NASDAQ NYMX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 90 (Vote Outperform)Underperform Votes: 87 (Vote Underperform)Total Votes: 177MarketBeat's community ratings are surveys of what our community members think about Nymox Pharmaceutical and other stocks. Vote "Outperform" if you believe NYMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NYMX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/21/2018 by MarketBeat.com StaffFeatured Article: What are earnings reports?